Research Paper Volume 15, Issue 7 pp 2503—2524
NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis
Figure 6. (A) OS of NCAPG (218663-s-at) in BRCA (n = 1879), OS of NCAPG (218663-at) in BRCA (n = 1879), (B) RFS of NCAPG (218663-s-at) in BRCA (n = 4929), RFS of NCAPG (218663-at) in BRCA (n = 4929), (C) PPS of NCAPG (218663-s-at) in BRCA (n = 458), PPS of NCAPG (218663-at) in BRCA (n = 458)(D) DMPS of NCAPG (218663-s-at) in BRCA (n = 2765), DMPS of NCAPG (218663-at) in BRCA (n = 2765), (E) OS (n = 364), PFS (n = 316), PFS (n = 370)and DSS (n = 362)of NCAPG in LIHC, (F) OS of NCAPG (218663-s-at) in lung cancer (n = 1925), OS of NCAPG (218663-at) in lung cancer (n = 1925), (G) FP of NCAPG (218663-s-at) in lung cancer (n = 982), FP of NCAPG (218663-at) in lung cancer (n = 982), (H) PPS of NCAPG (218663-s-at) in lung cancer (n = 344), PPS of NCAPG (218663-at) in lung cancer (n = 344), (I) OS of NCAPG (218663-s-at) in STAD (n = 592), OS of NCAPG (218663-at) in STAD (n = 592), (J) FP of NCAPG (218663-s-at) in STAD (n = 358), FP of NCAPG (218663-at) in STAD (n = 358), (K) PPS of NCAPG (218663-s-at) in STAD (n = 221), PPS of NCAPG (218663-at) in STAD (n = 221).